Skip to main content

Fate Therapeutics Inc

FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001434316

In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Fate Therapeutics Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
139
+7 vs. Q1 2025
Shares held
79.7M
−16.9M (−17.5%) vs. Q1 2025
Total value
$88.9M
+$12.6M (+16.5%) vs. Q1 2025
New holders
28
45 more added
Sold out
21
40 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 139 institutions
Q1 2021: 260 institutionsQ2 2021: 272 institutionsQ3 2021: 266 institutionsQ4 2021: 250 institutionsQ1 2022: 249 institutionsQ2 2022: 233 institutionsQ3 2022: 239 institutionsQ4 2022: 228 institutionsQ1 2023: 182 institutionsQ2 2023: 188 institutionsQ3 2023: 171 institutionsQ4 2023: 159 institutionsQ1 2024: 167 institutionsQ2 2024: 182 institutionsQ3 2024: 164 institutionsQ4 2024: 159 institutionsQ1 2025: 132 institutionsQ2 2025: 139 institutionsQ3 2025: 143 institutionsQ4 2025: 146 institutionsQ1 2026: 158 institutionsQ2 2026: 156 institutions
Value heldQ2 2025: $88.9M
Q1 2021: $7.73BQ2 2021: $8.20BQ3 2021: $5.67BQ4 2021: $5.66BQ1 2022: $3.92BQ2 2022: $2.70BQ3 2022: $2.41BQ4 2022: $1.07BQ1 2023: $641.6MQ2 2023: $519.6MQ3 2023: $202.9MQ4 2023: $357.2MQ1 2024: $904.0MQ2 2024: $401.1MQ3 2024: $401.6MQ4 2024: $166.5MQ1 2025: $76.3MQ2 2025: $88.9MQ3 2025: $101.6MQ4 2025: $70.9MQ1 2026: $88.9MQ2 2026: $193.2M
Institutions holding FATE and their total value by quarter
QuarterHoldersValue
Q2 2026156$193.2M
Q1 2026158$88.9M
Q4 2025146$70.9M
Q3 2025143$101.6M
Q2 2025139$88.9M
Q1 2025132$76.3M
Q4 2024159$166.5M
Q3 2024164$401.6M
Q2 2024182$401.1M
Q1 2024167$904.0M
Q4 2023159$357.2M
Q3 2023171$202.9M
Q2 2023188$519.6M
Q1 2023182$641.6M
Q4 2022228$1.07B
Q3 2022239$2.41B
Q2 2022233$2.70B
Q1 2022249$3.92B
Q4 2021250$5.66B
Q3 2021266$5.67B
Q2 2021272$8.20B
Q1 2021260$7.73B

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q1 2025.

Institutions holding FATE in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Legal & General Group Plc10,398$11.7K0.00%+1,754+20.3%Added
Franklin Resources Inc10,197$11.4K0.00%00.0%Unchanged
Financial Engines Advisors L.L.C.10,072$11.2K0.00%−10.0%Reduced
Ameritas Investment Partners, Inc.8,358$9.36K0.00%00.0%Unchanged
California State Teachers Retirement System7,254$8.12K0.00%00.0%Unchanged
Mirae Asset Global Investments Co., Ltd.4,428$4.96K0.00%+486+12.3%Added
Advisor Group Holdings, Inc.3,385$3.79K0.00%+1,180+53.5%Added
Dunhill Financial, LLC3,180$3.56K0.00%00.0%Unchanged
Sterling Capital Management LLC2,828$3.17K0.00%+1,029+57.2%Added
GF Fund Management Co. Ltd.2,737$3.06K0.00%00.0%Unchanged
Amalgamated Bank2,912$3.00K0.00%00.0%Unchanged
Geneos Wealth Management Inc.1,800$2.02K0.00%+1,800New
The PNC Financial Services Group, Inc.1,480$1.66K0.00%−2,431−62.2%Reduced
Raymond James Financial Inc1,450$1.62K0.00%+1,450New
SBI Securities Co., Ltd.1,436$1.61K0.00%+707+97.0%Added
EverSource Wealth Advisors, LLC1,238$1.39K0.00%−1,284−50.9%Reduced
Optiver Holding B.V.1,129$1.26K0.00%+2+0.2%Added
UMA Financial Services, Inc.1,094$1.23K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC987$1.10K0.00%−1,323−57.3%Reduced
Toronto Dominion Bank850$9520.00%+850New
Jones Financial Companies LLLP900$9360.00%00.0%Unchanged
Parkside Financial Bank & Trust670$7510.00%+670New
Clearstead Advisors, LLC642$7200.00%+642New
Rise Advisors, LLC633$7090.00%+633New
Essential Partners LLC622$6970.00%+622New
True Wealth Design, LLC562$6300.00%−359−39.0%Reduced
Fortitude Family Office, LLC391$4380.00%+391New
Mark Sheptoff Financial Planning, LLC300$3360.00%00.0%Unchanged
Hilltop National Bank285$3190.00%+285New
Albion Financial Group225$2520.00%00.0%Unchanged
Twin Peaks Wealth Advisors, LLC200$1870.00%+200New
Boreal Capital Management LLC100$1120.00%+100New
Federation des caisses Desjardins du Quebec95$1060.00%00.0%Unchanged
IFP Advisors, Inc85$960.00%+85New
Point72 Asia (Singapore) Pte. Ltd.50$560.00%+50New
Smartleaf Asset Management LLC35$360.00%00.0%Unchanged
Leonteq Securities AG19$210.00%00.0%Unchanged
Allworth Financial LP4$50.00%00.0%Unchanged
Avion Wealth625$00.00%+625New
OrbiMed Advisors LLC0$00.00%−1,680,580−100.0%Sold out
Integral Health Asset Management, LLC0$00.00%−700,000−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−433,192−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−397,177−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−131,830−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−118,186−100.0%Sold out
Comerica Bank0$00.00%−82,024−100.0%Sold out
Callan Family Office, LLC0$00.00%−82,024−100.0%Sold out
Walleye Capital LLC0$00.00%−72,286−100.0%Sold out
Caption Management, LLC0$00.00%−57,000−100.0%Sold out
Corebridge Financial, Inc.0$00.00%−49,045−100.0%Sold out
Marshall Wace, LLP0$00.00%−19,155−100.0%Sold out
Wilshire Advisors LLC0$00.00%−4,083−100.0%Sold out
Stifel Financial Corp0$00.00%−11,250−100.0%Sold out
Federated Hermes, Inc.0$00.00%−5,942−100.0%Sold out
Picton Mahoney Asset Management0$00.00%−5,369−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−686−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−255−100.0%Sold out
Legacy Wealth Managment, LLC0$00.00%−115−100.0%Sold out
Rothschild Investment LLC0$00.00%−70−100.0%Sold out
Covestor Ltd0$00.00%−31−100.0%Sold out